tag:blogger.com,1999:blog-4241416962008169508.post6890458914061969845..comments2024-03-29T10:23:47.050-04:00Comments on Just A Life Sciences Blog...: Excellent Daxas® Follow-Up Analysis, From An Anonymous CommenterUnknownnoreply@blogger.comBlogger2125tag:blogger.com,1999:blog-4241416962008169508.post-12190784259430892952012-07-31T14:58:41.839-04:002012-07-31T14:58:41.839-04:00Nycomed (more strictly Byk Gulden) was the origina...Nycomed (more strictly Byk Gulden) was the originator of both Daxas and ciclesonide.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-4241416962008169508.post-42280924969286683322012-01-26T12:19:37.788-05:002012-01-26T12:19:37.788-05:00Thanks for the nod.
You were right and as a follo...Thanks for the nod.<br /><br />You were right and as a follow up, Merck is still pursuing the CXCR2 compound for COPD (http://www.clinicaltrials.gov/ct2/show/NCT01068145?spons=%22Schering-Plough%22&spons_ex=Y&rank=280 )<br /><br />Though, I wonder why it isn't on the Merck Clinical pipleline listed on the website.<br /><br />Cheers-Anonymousnoreply@blogger.com